ImmunAbs Inc. Alternatives & Competitors
12 companies similar to ImmunAbs Inc. — ImmunAbs Inc. is Specialized Antibody Pharmaceutical Development Biotech Venture...
Companies similar to ImmunAbs Inc.
Dualyx
Discovery and development of highly innovative biologicals for the treatment of autoimmune...
Belgium
Tridek-One
We develop first-in-class CD31 checkpoint agonists for the treatment of auto-immune diseas...
Paris, France
Pinteon Therapeutics
Pioneering therapies targeting Pin1 to normalize disease processes and enhance patient out...
Biomed Valley Discoveries
Biotech, Purposefully Reimagined
Kansas City, United State...
Track all ImmunAbs Inc. competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Antharis Therapeutics, Inc.
Antharis Therapeutics is a multinational biopharmaceutical company developing new, cutting...
San Diego, United States
PrecisemAb Biotech Co., Ltd.
We are committed to changing the world to be better by creating safer and disease-directed...
Taiwan
Ablexis, LLC
A superior, next generation transgenic platform.
San Diego, United States
South San Francisco, Unit...
Korea South
Alvine Pharmaceuticals
Pioneering solutions for autoimmune and gastrointestinal health with a promising treatment...
Planet Biotechnology, Inc.
Developing promising antibodies and receptor/ligand-Fc fusion proteins for the treatment a...
Cancer Research Horizons
We are Cancer Research UK's innovation arm, translating discovery into breakthrough treatm...
London, United Kingdom
About ImmunAbs Inc.
ImmunAbs Inc., founded in 2017, is a promising player in the Biotechnology sector, focused on addressing autoimmune diseases via specialized antibody therapeutics. The company is led by a team with extensive experience, positioning itself as a significant contributor to the Health Care and Health and Wellness industrie...
Antibody Therapeutics, Autoimmune Diseases, Orphan Diseases, Diabetic Retinopathy, Diabetes Treatments, Biopharmaceuticals, Phase 1 Clinical Trial, Phase 2 Clinical Trial, Pharmaceutical Development, Biotech Venture, Antibody-Based Therapeutics, Clinical Trials, Global Standard Development, Expert Team In Antibodies, Therapeutics Approval
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches ImmunAbs Inc. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at ImmunAbs Inc. on 2 Apr 2026. The 12 companies listed here were last checked between 17 Jun 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
